Tscan Therapeutics, Inc. · NASDAQ:TCRX
K2 HealthVentures Equity Trust LLC reported a 6.90% stake in Tscan Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
K2 HealthVentures Equity Trust LLC reported a 6.90% stake in Tscan Therapeutics, Inc., 3,602,700 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 6.90%
- Shares
- 3,602,700
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| K2 HealthVentures Equity Trust LLC | 6.90% | 3,602,700 |
| Parag Shah | 6.90% | 3,602,700 |
| Anup Arora | 6.90% | 3,602,700 |
Source
Related
- Tscan Therapeutics, Inc.
- K2 HealthVentures Equity Trust LLC
- Tscan Therapeutics, Inc. shareholders
- Form 4 · MacBeath Gavin · Oct 2, 2026
- Form 4 · Zdraveski Zoran · Oct 2, 2026
- Schedule 13G · Readout Capital, LP · Sep 25, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026